Nociplastic Pain: Difference between revisions
Kapil Narale (talk | contribs) No edit summary |
Kapil Narale (talk | contribs) No edit summary |
||
| Line 37: | Line 37: | ||
Generally, the experience of pain involves contribution from all 3 categories. Feel free to see Table 1 in Buldy's et al (2023) for an outline of the 3 pathophysiological mechanisms of nociplastic pain. <ref name=":2" /> | Generally, the experience of pain involves contribution from all 3 categories. Feel free to see Table 1 in Buldy's et al (2023) for an outline of the 3 pathophysiological mechanisms of nociplastic pain. <ref name=":2" /> | ||
The most likely cause of Nociceptive Pain may be attributed to a biopsychosocial model, which would attribute to a variety of facets and classifications leading to nociplastic pain. Such factors can include abuse (overdosing), environmental toxins, and genetic | |||
== Testing and Diagnosis == | == Testing and Diagnosis == | ||
In a study concerning nociplastic pain in mice, it was noted to be easier to induce nociplastic pain in female mice compared to male mice. There were also differences noted in pain mediation between male and female models, with male mice showing greater hypersensitivity than female mice. This activity is dictated by the microglia in the spinal cord. With the female model, there was minimal sensory activity outside the injured location making the microglia less hypersensitive outside the injured location. | |||
Other studies indicate that brain plasticity may be the sole contributor to nociplastic changes. | |||
The onset and severity of nociplastic pain can be correlated with heightened primary emotions, such as anger, and secondary emotions which are emotional reactions to primary emotions. A study on low back patient indicated that varied mapping of the organization of the primary motor cortex, which may be the origin of nociplastic pain, when considering low back pain. | |||
As correlated with [[fibromyalgia]], there was a correlation between c-reactive protein and the magnitude and intensity of pain that is experienced. | |||
== Diagnosis == | |||
Diagnostic tools for neuropathic pain such as the painDETECT and Douleur Neuropathique 4 questionnaire can be used to detect nociplastic pain. <ref name=":2" /> | Diagnostic tools for neuropathic pain such as the painDETECT and Douleur Neuropathique 4 questionnaire can be used to detect nociplastic pain. <ref name=":2" /> | ||
Revision as of 20:29, 13 August 2023
Original Editor - Kapil Narale
This article or area is currently under construction and may only be partially complete. Please come back soon to see the finished work! (13/08/2023)
Top Contributors - Kapil Narale, Kim Jackson, Ewa Jaraczewska, Candace Goh, Melissa Coetsee and Sehriban Ozmen
IASP Definition[edit | edit source]
Until 2017, pain mechanisms have been divided into “nociceptive pain” and “neuropathic pain”. Since these only include pain from two specific sources, there are a large group of patients without a valid pathophysiological identification for their experience of pain. This pain experienced is neither nociceptive nor neuropathic. Thus, this group comprises people who have neither obvious activation of nociceptors nor neuropathy, but clinical and psychophysical findings suggest altered nociceptive function. [1]
Recommended by the IASP, "Nociplastic Pain is a term used to describe persistent pain that arises from altered nociception, despite no clear evidence of actual or threatened tissue damage causing the activation of peripheral nociceptors, or evidence for disease or lesion of the somatosensory system causing the pain."[1] [2]
Types of conditions that fall under the umbrella of Nociplastic Pain include: fibromyalgia, complex regional pain syndrome, other types of musculoskeletal pain such as chronic low back pain, visceral pain disorders such as irritable bowel syndrome and bladder pain syndrome. [1]
It is seen that there isn't a single term that is fully suitable for describing someone's pain, and the pain experience can overlap between the 3 terms of nociceptive, neuropathic, and nociplastic pain. The terms describe one element or dimension o fthe pain experience. [1][2]
Nociplastic Pain is not a diagnosis, but a descriptor of the pain that is being experienced. [1][2]
Pathophysiology[edit | edit source]
Nociplastic Pain is often mixed with central sensitisation. [3]
Nociplastic pain does not involve tissue damage that can activate nociceptors. It also does not involve nerve damage which would lead to neuropathic pain. However, it is present in chronic conditions. [3]
Nociplastic Pain can be divided into 3 categories: [3]
- Supraspinal mechanism - hyperresponsiveness to pain stimuli, hyperactivity, connectivity between regions of the brain in charge of pain perception
- Nociplastic pain is believed to be equipped with decreased connectivity and activity of brain areas for pain inhibition.
- There is an increased concentration of Substance P and glutamine levels in cerebrospinal fluid, with inhibition of GABAergic transmission
- Variance also exists n the shape and size of grey and white matter in areas relating to pain
- Spinal mechanisms - this involves regional clustering and narrowing of signals from different pain loci spinal cord reorganisation, amplified spinal reflex transmission, and decreased spinal inhibition
- Peripheral Mechanisms - this is related to the proliferation of sodium channels and sympatho-afferent coupling
Generally, the experience of pain involves contribution from all 3 categories. Feel free to see Table 1 in Buldy's et al (2023) for an outline of the 3 pathophysiological mechanisms of nociplastic pain. [3]
The most likely cause of Nociceptive Pain may be attributed to a biopsychosocial model, which would attribute to a variety of facets and classifications leading to nociplastic pain. Such factors can include abuse (overdosing), environmental toxins, and genetic
Testing and Diagnosis[edit | edit source]
In a study concerning nociplastic pain in mice, it was noted to be easier to induce nociplastic pain in female mice compared to male mice. There were also differences noted in pain mediation between male and female models, with male mice showing greater hypersensitivity than female mice. This activity is dictated by the microglia in the spinal cord. With the female model, there was minimal sensory activity outside the injured location making the microglia less hypersensitive outside the injured location.
Other studies indicate that brain plasticity may be the sole contributor to nociplastic changes.
The onset and severity of nociplastic pain can be correlated with heightened primary emotions, such as anger, and secondary emotions which are emotional reactions to primary emotions. A study on low back patient indicated that varied mapping of the organization of the primary motor cortex, which may be the origin of nociplastic pain, when considering low back pain.
As correlated with fibromyalgia, there was a correlation between c-reactive protein and the magnitude and intensity of pain that is experienced.
Diagnosis[edit | edit source]
Diagnostic tools for neuropathic pain such as the painDETECT and Douleur Neuropathique 4 questionnaire can be used to detect nociplastic pain. [3]
Comparison of Definitions[edit | edit source]
As can be seen, Nociplastic Pain is a 3rd dimension of Pain classification.
Nociception, Neuropathic, and Nociplastic Pain can be described by the IASP in the definitions on the following pages..
The definitions are explained in the following video:
Resources[edit | edit source]
References[edit | edit source]
- ↑ 1.0 1.1 1.2 1.3 1.4 International Association for the Study of Pain - What's in a Name for Chronic Pain? “Nociplastic pain” officially adopted by IASP as third mechanistic descriptor of chronic pain. Available from: https://www.iasp-pain.org/publications/pain-research-forum/prf-news/92059-whats-name-chronic-pain/ (accessed 11 August 2023).
- ↑ 2.0 2.1 2.2 Slater H, Hush J. Pain Terminology: Introduction Of a Third Clinical Descriptor. Pain Terminology. 2018:3:7-8.
- ↑ 3.0 3.1 3.2 3.3 3.4 Bułdys K, Górnicki T, Kałka D, Szuster E, Biernikiewicz M, Markuszewski L, Sobieszczanska M. What Do We Know about Nociplastic Pain? Healthcare. 2023:11(1794):1-14.
- ↑ Dr. Andrea Furlan. #079Nociceptive, Neuropathic, Nociplastic Pain. Available from: https://www.youtube.com/watch?v=bNdxG5cYW0E&ab_channel=Dr.AndreaFurlan (accessed 11 August 2023).
